HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.

Abstract
Immune system modulates atherosclerosis and immunization using homologous LDL reduces atherosclerosis in hyperlipidemic animals. The nature of athero-protective antigenic epitopes in LDL remains unclear. We have recently identified nearly a 100 antigenic epitopes in human apo B-100 and in this study we evaluated the effects of immunization with two such epitopes on atherosclerosis in hypercholesterolemic apo E (-/-) mice. Male apo E (-/-) mice were immunized at 6-7 weeks of age with two different apo B-100 related peptide sequences using alum as adjuvant and mice immunized with alum alone served as controls. Peptide-2 immunization reduced aortic atherosclerosis by 40% and plaque inflammation by 80% compared to controls without a reduction in circulating cholesterol levels whereas Peptide-1 immunization had no effect. Peptide-2 immunization also reduced the progression of aortic lesions when mice were immunized at 16 weeks of age, suggesting the possibility of immuno-modulation in treating established atherosclerosis. The athero-protective effect of Peptide-2 immunization was absent in splenectomized mice but could be conveyed to non-immunized mice via adoptive transfer of splenocytes from peptide-2 immunized mice. In conclusion, immunization with a specific apo B-100 related peptide sequence reduces aortic atherosclerosis and plaque inflammation. Such acquired immunity and athero-protective effect appears to be mediated by splenocytes. These data demonstrate the feasibility of peptide based immunomodulating therapy for atherosclerosis.
AuthorsKuang-Yuh Chyu, Xiaoning Zhao, Odette S Reyes, Stephanie M Babbidge, Paul C Dimayuga, Juliana Yano, Bojan Cercek, Gunilla Nordin Fredrikson, Jan Nilsson, Prediman K Shah
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 338 Issue 4 Pg. 1982-9 (Dec 30 2005) ISSN: 0006-291X [Print] United States
PMID16288717 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein B-100
  • Apolipoproteins B
  • Apolipoproteins E
  • Epitopes
  • Cholesterol
Topics
  • Adoptive Transfer
  • Animals
  • Apolipoprotein B-100
  • Apolipoproteins B (immunology)
  • Apolipoproteins E (deficiency)
  • Atherosclerosis (pathology, prevention & control, therapy)
  • Cholesterol (blood)
  • Epitopes (immunology)
  • Hypercholesterolemia (immunology, pathology)
  • Immunization
  • Immunotherapy, Adoptive
  • Inflammation (therapy)
  • Male
  • Mice
  • Spleen (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: